Article metrics

PDF

Extended report
MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial

Statistics from Altmetric.com

Online download statistics by month:

Online download statistics by month: February 2014 to February 2019

AbstractFullPdf
Feb 2014519111162
Mar 2014157129102
Apr 2014728473
May 2014446053
Jun 2014345740
Jul 2014606050
Aug 2014413934
Sep 2014327546
Oct 2014406341
Nov 2014343328
Dec 2014393620
Jan 2015534635
Feb 2015384536
Mar 2015655838
Apr 2015375435
May 20151045113205
Jun 20154716271
Jul 20151896945
Aug 20151534239
Sep 20151614433
Oct 2015833621
Nov 2015874533
Dec 2015794224
Jan 2016815050
Feb 2016973221
Mar 2016502626
Apr 2016793630
May 2016812526
Jun 2016393239
Jul 2016632924
Aug 2016621824
Sep 2016733020
Oct 2016613517
Nov 2016433129
Dec 201626155
Jan 2017514316
Feb 2017174622
Mar 201754818
Apr 201777319
May 201755836
Jun 2017295851
Jul 2017625340
Aug 201714613044
Sep 20171097224
Oct 20171268630
Nov 201721217436
Dec 201729725640
Jan 201826824661
Feb 201820217734
Mar 201822817634
Apr 201814111939
May 201814110423
Jun 20181048416
Jul 201812410024
Aug 20181139516
Sep 2018857113
Oct 201814311744
Nov 20181261148
Dec 20181028014
Jan 201917615824
Feb 20191058017
Total741245802318